Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Titi Chen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Immunology (Orlando, Fla.)|March 18, 2023
Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM diseaseTiti Chen, Qi Cao, Ruifeng Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2018
Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activationRuifeng Wang, Titi Chen, Chengshi Wang, et al.
The American Journal of Pathology|March 23, 2021
Promotion of β-Catenin/Forkhead Box Protein O Signaling Mediates Epithelial Repair in Kidney InjuryPadmashree Rao, Xi Qiao, Winston Hua, et al.
Nature Biomedical Engineering|May 7, 2025
Targeting inflammation with chimeric antigen receptor macrophages using a signal switchQi Cao, Yiping Wang, Jianwei Chen, et al.
Kidney International|August 31, 2022
Barriers to accessing essential medicines for kidney disease in low- and lower middle-income countries|Anna Francis, Muhammad Iqbal Abdul Hafidz, Udeme E Ekrikpo, et al.
Frontiers in Immunology|May 31, 2021
Conventional Type 1 Dendritic Cells (cDC1) in Human Kidney Diseases: Clinico-Pathological CorrelationsTiti Chen, Qi Cao, Ruifeng Wang, et al.
Kidney International|November 6, 2019
Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injuryQi Cao, Ruifeng Wang, Yiping Wang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 2, 2020
Renal tubular cell binding of β-catenin to TCF1 versus FoxO1 is associated with chronic interstitial fibrosis in transplanted kidneysYing Yang, Brian J Nankivell, Winston Hua, et al.
Kidney International Reports|September 14, 2023
Nurturing Global Leadership, Advocacy, Research, and Collegiality: The Unique Experience of The International Society of Nephrology Emerging Leaders ProgramSabine Karam, Muhammad Iqbal Abdul Hafidz, Viviane Calice-Silva, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2018
Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion InjuryQi Cao, Yiping Wang, Zhiguo Niu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|March 18, 2023
Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM diseaseTiti Chen, Qi Cao, Ruifeng Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2018
Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activationRuifeng Wang, Titi Chen, Chengshi Wang, et al.
The American Journal of Pathology|March 23, 2021
Promotion of β-Catenin/Forkhead Box Protein O Signaling Mediates Epithelial Repair in Kidney InjuryPadmashree Rao, Xi Qiao, Winston Hua, et al.
Nature Biomedical Engineering|May 7, 2025
Targeting inflammation with chimeric antigen receptor macrophages using a signal switchQi Cao, Yiping Wang, Jianwei Chen, et al.
Kidney International|August 31, 2022
Barriers to accessing essential medicines for kidney disease in low- and lower middle-income countries|Anna Francis, Muhammad Iqbal Abdul Hafidz, Udeme E Ekrikpo, et al.
Frontiers in Immunology|May 31, 2021
Conventional Type 1 Dendritic Cells (cDC1) in Human Kidney Diseases: Clinico-Pathological CorrelationsTiti Chen, Qi Cao, Ruifeng Wang, et al.
Kidney International|November 6, 2019
Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injuryQi Cao, Ruifeng Wang, Yiping Wang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 2, 2020
Renal tubular cell binding of β-catenin to TCF1 versus FoxO1 is associated with chronic interstitial fibrosis in transplanted kidneysYing Yang, Brian J Nankivell, Winston Hua, et al.
Kidney International Reports|September 14, 2023
Nurturing Global Leadership, Advocacy, Research, and Collegiality: The Unique Experience of The International Society of Nephrology Emerging Leaders ProgramSabine Karam, Muhammad Iqbal Abdul Hafidz, Viviane Calice-Silva, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2018
Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion InjuryQi Cao, Yiping Wang, Zhiguo Niu, et al.
Pageof 3